Italy Self-injection Devices Market Outlook

italy's self-injection devices market is anticipated to exhibit lucrative growth over the forecast period, 2018 to 2032. this is attributed to increasing the prevalence of injectable drugs, technological advancements, and increasing number of approval from regulatory bodies. self-injection devices are widely used in homecare settings for the administration of insulin, growth hormones, and other biologic drugs. in italy, the rising prevalence of chronic diseases such as diabetes, cancer, and others is anticipated to propel the demand for self-injection devices. according to the world health organization, the prevalence of diabetes in italy is 9.7%, which is higher than the european average of 8.8%. with the emergence of new diseases, the demand for self-injection devices is expected to surge in the coming years. the technological advancements in self-injection devices have had a significant impact on the self-injection devices market growth over the years. the increasing focus on the development of user-friendly, easy-to-use products, as well as the introduction of smarter drug-delivery devices has further boosted the market growth. for instance, in 2018, ypsomed holding ag, a switzerland-based medical supplies manufacturer, launched a new mylife ypsomate self-injection device which provides an ergonomic design and offers the best drug delivery experience to patients. furthermore, the increasing number of approvals from regulatory bodies is contributing to the growth of the italy self-injection devices market. in 2019, polidoc logica delle formulazioni, an italian medical device company obtained an approval from the italian ministry of health to market its smartinjector, a self-injection device, in the italian market. moreover, the improving healthcare infrastructure in italy is another factor boosting the italy self-injection devices market. the italian government has increased the healthcare spending, leading to an increase in the number of healthcare facilities. the presence of skilled healthcare professionals and advanced technologies are further driving the market growth. all in all, the increasing prevalence of chronic diseases and technological advancements are driving the demand for self-injection devices in italy. the increasing number of approvals from regulatory bodies and the improving healthcare infrastructure are likely to create lucrative opportunities for the market players in the coming years.